Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

GLP-1-based therapy: incretin mimetics (GLP-1 analogues) and incretin enhancers (DPP-4 inhibitors) are now available for the treatment of Type 2 diabetes. Initial combination therapy with a DPP-4 ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug your doctor prescribed.

Without insurance, they’re also costly. Wegovy (semaglutide) has a list price of $1,349.02 for a four-week supply. Competitor Zepbound (tirzepatide) is a smidge cheaper at $1,086.37. And as ...

Further back in development is an incretin conjugate called HCR-488 that should begin preclinical studies as a monthly weight loss option in the second half of this year. Another potential ...

The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct effects of these drugs is the subject of intense interest. Although reductions in ...

1 In this article, we explore the impact of incretin-mimetic drugs on muscle health and what can be done to limit these severe side effects. Incretins are intestinal hormones secreted in response to ...

Each person probably has a visceral fat threshold that is genetically determined. Incretin mimetics — GLP-1 receptor agonists and GLP-1/GIP receptor agonists — are the first class of drugs to ...